current user: public

anford Burnham Prebys Medical Discovery Institute
We are hiring bioinformatics experts and software developers. Join us!

Query: PF06317.9; L_TACVF/1-2207; Arenavirus RNA polymerase, from PfamA30U

Results of FFAS03 search in PfamA30U
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310    .  320    .  330    .  340    .  350    .  360    .  370    .  380    .  390    .  400    .  410    .  420    .  430    .  440    .  450    .  460    .  470    .  480    .  490    .  500    .  510    .  520    .  530    .  540    .  550    .  560    .  570    .  580    .  590    .  600    .  610    .  620    .  630    .  640    .  650    .  660    .  670    .  680    .  690    .  700    .  710    .  720    .  730    .  740    .  750    .  760    .  770    .  780    .  790    .  800    .  810    .  820    .  830    .  840    .  850    .  860    .  870    .  880    .  890    .  900    .  910    .  920    .  930    .  940    .  950    .  960    .  970    .  980    .  990    . 1000    . 1010    . 1020    . 1030    . 1040    . 1050    . 1060    . 1070    . 1080    . 1090    . 1100    . 1110    . 1120    . 1130    . 1140    . 1150    . 1160    . 1170    . 1180    . 1190    . 1200    . 1210    . 1220    . 1230    . 1240    . 1250    . 1260    . 1270    . 1280    . 1290    . 1300    . 1310    . 1320    . 1330    . 1340    . 1350    . 1360    . 1370    . 1380    . 1390    . 1400    . 1410    . 1420    . 1430    . 1440    . 1450    . 1460    . 1470    . 1480    . 1490    . 1500    . 1510    . 1520    . 1530    . 1540    . 1550    . 1560    . 1570    . 1580    . 1590    . 1600    . 1610    . 1620    . 1630    . 1640    . 1650    . 1660    . 1670    . 1680    . 1690    . 1700    . 1710    . 1720    . 1730    . 1740    . 1750    . 1760    . 1770    . 1780    . 1790    . 1800    . 1810    . 1820    . 1830    . 1840    . 1850    . 1860    . 1870    . 1880    . 1890    . 1900    . 1910    . 1920    . 1930    . 1940    . 1950    . 1960    . 1970    . 1980    . 1990    .
# Score Template Links and tools%idFirst MDETVSELKDLVRKHIPNRHEFAHQKDAFLSHCHSGSLLQEGFKLLSNLVELESCESHACHLNTCQKYVDVILSDHGIPCPTLPKVIPDGFKLTGKTLILLETFVRVNPEEFERKWKSDMTKLLNLKQDLLRSGITLVPVVDGRTNYSNRFTPEWVVERIRWLLIEILRKSRSSAEIDIEDQEYQRLIHSLSNVRNQSLGFENIECLKRNLLEYDDRLAKSLFVGVKGDVRESVIREELMKLRLWYKKEVFDKNLGKFRITNRSELLNNLIRLGKHEDNTTSDCPFCVNKFMDIIYSLTFTALKRQDREKSNSELDQYVVCPHEKAYLGVLSICNKIKGLKVFNTRRNTLLFLDLIMVNFLDDLFTAKPEALDSLRRSGLILGQMVTLVNDRALDFLEAVKLIKKKIETNVKWVENCSKILRRSQQDIWSQISVWARYPDLSKLISIAQTISSDRPIMRYSAGGNFNTECKHKTFHMMSDAEQVEAFKILSSVSLSLINSMKTSFSSRLLINEKEYSRYFGNVRLRECYQQRFFLTDGLIVILFYQKTGERSGCYSIYTCEDGVLVEKGSFYCDPKRFFLPIFSQEVLVEMCDEMTTWLDFNSDLMVISKEKLRLLLLSILCAPSKRNQVFLQGLRYFLMAYSNQFHHVDLLSKLKVECMSGSEVIVQRLAVDLFQCLLGEGVDSDPYFARRFKYLLNVSYLCHLITKETPDRLTDQIKCFEKFIEPKIDFNCVIVNPSLNGQLTEAQEGMMLDGLDKFYSKTLKDCSDTKLPGVSNELLSYCISLFNKGKLKVTGELKNDPFKPNITSTALDLSSNKSVVVPKLDELGNVLSVYDREKMISSCVSSMAERFKTKGRYNIDPSTLDYLILKNLTGLVSIGSKTQRDCEELSMMFEGLTEEQAEAFNDIKNSVQLAMVKMKDSKSGDVNLSPNQKEGRVKSSTGTLEELWGPFGIMREIRTEVSLHEVKDFDPDVLASDLYKELCDVVYYSSSKPEYFLERPLEVCPLGLLLKNLTTSAYFDEEYFECFKYLLIQGHYDQKLGSYEHRSRSRLGFTNEALRVKDEVRLSMRESNSEAIADKLDRSYFTNAALRNLCFYSDDSPTEFTSISSNNGNLKFGLSYKEQVGSNRELYVGDLNTKLITRLVEDFAEAVGSSMRYTCLSSEKEFDRAICDMKLAVNNGDLSCSLDHSKWGPTMSPALFLTFLQFLELRTPKERNIINLEPVLNVLRWHLHKVIEVPVNVAEAYCTGNLKRSLGLMGCGSSSVGEEFFHQFMPVQGEIPSHIMSVLDMGQGILHNMSDLYGLITEQFLNYVLDLLYDVIPTSYTSSDDQVTLIKLPCASDDNQVNDEWLEMLCFHEYLSSKLNKFVSPKSVAGTFVAEFKSRFFVMGEETPLLTQFVAAALHNVKCKTPTQLSETIDTICDQCVANGVSVQIVSKISQRVNQLIKYSGFKETPFGAVEKQDVKDWVDGTRGYRLQRKIESIFSDDEMTGFIRSCAKRVFNDIKRGKVFEENLISLIGRDGDDALVGFLRYSSCSEQDIMRALGFRWVNLSSFGDLRLVLRTKLMTSRRVLEREEVPTLIKTLQSRLSRNFTKGVKKILAESINKSAFQSSVASGFIGFCKSIGSKCVRDGEGGFLYIKDIYTKVKPCLCEVCNMKRGVIYCRPSLEKIEKFSKPILWDYFSLVLTNACEIGEWVFSSVKEPQIPVVLSNRNLFWAVKPRIVRQLEDQLGMNHVLYSIRKNYPKLFDEHLSPFMSDLQVNRTLDGRKLKFLDVCIALDLMNENLGIVSHLLKARDNSVYIVKQSDCAMAHVRQSDYVDKEVGLSPQQVCYNFMVQIILSSMVNPLVMSTSCLKSFFWFNEVLELEDDGQIELGELTDFTFLVRDQKISRAMFIEDIAMGYVISNLEDVRLYIDKITIGEQPLAPGRHINDLLDLLGNFDDHEDCDLRFLIQVEHSRTSTKYRFKRKMTYSFSVTCVSKVIDLKEASVELQVVDVTQSVLast
1 -494.000PF06317.9; L_TACVF/1-2207; Arenavirus RNA polymerase  ali  100  1MDETVSELKDLVRKHIPNRHEFAHQKDAFLSHCHSGSLLQEGFKLLSNLVELESCESHACHLNTCQKYVDVILSDHGIPCPTLPKVIPDGFKLTGKTLILLETFVRVNPEEFERKWKSDMTKLLNLKQDLLRSGITLVPVVDGRTNYSNRFTPEWVVERIRWLLIEILRKSRSSAEIDIEDQEYQRLIHSLSNVRNQSLGFENIECLKRNLLEYDDRLAKSLFVGVKGDVRESVIREELMKLRLWYKKEVFDKNLGKFRITNRSELLNNLIRLGKHEDNTTSDCPFCVNKFMDIIYSLTFTALKRQDREKSNSELDQYVVCPHEKAYLGVLSICNKIKGLKVFNTRRNTLLFLDLIMVNFLDDLFTAKPEALDSLRRSGLILGQMVTLVNDRALDFLEAVKLIKKKIETNVKWVENCSKILRRSQQDIWSQISVWARYPDLSKLISIAQTISSDRPIMRYSAGGNFNTECKHKTFHMMSDAEQVEAFKILSSVSLSLINSMKTSFSSRLLINEKEYSRYFGNVRLRECYQQRFFLTDGLIVILFYQKTGERSGCYSIYTCEDGVLVEKGSFYCDPKRFFLPIFSQEVLVEMCDEMTTWLDFNSDLMVISKEKLRLLLLSILCAPSKRNQVFLQGLRYFLMAYSNQFHHVDLLSKLKVECMSGSEVIVQRLAVDLFQCLLGEGVDSDPYFARRFKYLLNVSYLCHLITKETPDRLTDQIKCFEKFIEPKIDFNCVIVNPSLNGQLTEAQEGMMLDGLDKFYSKTLKDCSDTKLPGVSNELLSYCISLFNKGKLKVTGELKNDPFKPNITSTALDLSSNKSVVVPKLDELGNVLSVYDREKMISSCVSSMAERFKTKGRYNIDPSTLDYLILKNLTGLVSIGSKTQRDCEELSMMFEGLTEEQAEAFNDIKNSVQLAMVKMKDSKSGDVNLSPNQKEGRVKSSTGTLEELWGPFGIMREIRTEVSLHEVKDFDPDVLASDLYKELCDVVYYSSSKPEYFLERPLEVCPLGLLLKNLTTSAYFDEEYFECFKYLLIQGHYDQKLGSYEHRSRSRLGFTNEALRVKDEVRLSMRESNSEAIADKLDRSYFTNAALRNLCFYSDDSPTEFTSISSNNGNLKFGLSYKEQVGSNRELYVGDLNTKLITRLVEDFAEAVGSSMRYTCLSSEKEFDRAICDMKLAVNNGDLSCSLDHSKWGPTMSPALFLTFLQFLELRTPKERNIINLEPVLNVLRWHLHKVIEVPVNVAEAYCTGNLKRSLGLMGCGSSSVGEEFFHQFMPVQGEIPSHIMSVLDMGQGILHNMSDLYGLITEQFLNYVLDLLYDVIPTSYTSSDDQVTLIKLPCASDDNQVNDEWLEMLCFHEYLSSKLNKFVSPKSVAGTFVAEFKSRFFVMGEETPLLTQFVAAALHNVKCKTPTQLSETIDTICDQCVANGVSVQIVSKISQRVNQLIKYSGFKETPFGAVEKQDVKDWVDGTRGYRLQRKIESIFSDDEMTGFIRSCAKRVFNDIKRGKVFEENLISLIGRDGDDALVGFLRYSSCSEQDIMRALGFRWVNLSSFGDLRLVLRTKLMTSRRVLEREEVPTLIKTLQSRLSRNFTKGVKKILAESINKSAFQSSVASGFIGFCKSIGSKCVRDGEGGFLYIKDIYTKVKPCLCEVCNMKRGVIYCRPSLEKIEKFSKPILWDYFSLVLTNACEIGEWVFSSVKEPQIPVVLSNRNLFWAVKPRIVRQLEDQLGMNHVLYSIRKNYPKLFDEHLSPFMSDLQVNRTLDGRKLKFLDVCIALDLMNENLGIVSHLLKARDNSVYIVKQSDCAMAHVRQSDYVDKEVGLSPQQVCYNFMVQIILSSMVNPLVMSTSCLKSFFWFNEVLELEDDGQIELGELTDFTFLVRDQKISRAMFIEDIAMGYVISNLEDVRLYIDKITIGEQPLAPGRHINDLLDLLGNFDDHEDCDLRFLIQVEHSRTSTKYRFKRKMTYSFSVTCVSKVIDLKEASVELQVVDVTQSV 1999
2 -59.500PF04196.10; RDRP_RSVT/1066-1804; Bunyavirus RNA dependent RNA polymerase  ali follow..  15  33..........................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................MAEPDSVCQMMSWTLL-ILLNDKHQLEEMITVSRFVHMEGFVTFPAWPMFDKLSVTPRSRLECLVIKRLIMLMKHYSENPIKFMI--LSDQDQMLNLFYLGYLKNKDEEVEDNGMGQLLTKILGFESAM----------------------PKTRDFLGMKDPEYGTIKKHEFSISYVKDLCDKFLD----------------------------------------RLKKTHGIKDPITYLGDKIAKF-------------------------------------------------------------------------------------------------------------------------------------------------------------------LSTQFIETMASLKASSNFSEDYYLYTPSRRLKNQEQSRSKHVIDAGGNISASVKGKLYHRSKVIEKLTTLIKDETPGKELKI-VVDLLPKAMEVLNKNECMHICIFKKNQHGGLREIYVLNIFERIMQKTVEDFSRAILECCPSETMTSPKNKFRIPELKTLKNEYMTISTSDDASKWNQGHYVSKFMCMLLRLT-------PTYYHGFLVQALQLWHHKKIFLGDQLLQLFNQ---NAMLNTMDTTLMKVFQAYKGEIQVP-KAGRSYIETETGMMQGILHYTSSLFHAIFLDQLAEECRRDISCIVNNMESSDDSSFIISIPNFKENEAAQLYLLCWFRKKEKLGTYLGIYKSPKSTQTLFVMEFNSEFFFSGDVHRPTFRWVNAAVLIGEQETLSGIQEELSNTLKDVIEGGGTYALTFIVQ-VAQAMIHYLGSSASSVWPAYETLLKNSYDPALGFFLMDN-----PKCAGLLGFNYNV...................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 739
3 -18.300PF00602.15; RDRP_INCAA/1-738; Influenza RNA-dependent RNA polymerase subunit PB1  ali follow..  12  228.............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................TMAKDGERGQRRAIATPGMIVRPFSKIVETVAQKICEKLKESGLPVGGNEKKAKLKTTVTSDQFAVNITGDNSKWNECQQPEAYLALLAYITKDSSDL----MKDLCSVAPVLFCNKFVKLGQGIRLSNKRKTKEVIIKAEKMGKYKNLMREEYKNLFEPLE-KDVCFLPGGMLMGMFNMLSTVLGVSTLCYMDEELKA--GCFWTGLQSSDDFVLFAVASNWSN-------IHWTIRRFNAVCKLIGINMSLEKSSLPELFEFTSMFFDGEFVSNLAME---LPAFTTAGVNEGVDFTAAMSIIKTNMINN.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 538
4 -11.100PF02514.14; Q2JMZ0_SYNJB/187-1302; CobN/Magnesium Chelatase  ali follow..  10  231MQDRIELIAARAIKWANLRRK-LEKKIAITVFSFPPD-VGTAAYL-SIHRVMQALAHNGYDLGPEQELMESILREYEALTPYVKAIEPGHLNTDGQNLLI-NVFIGVQPT---FGYEGDPMRLLFLEKVWGADAVL-LEFMPGKQGMSGECYPDNLIGSLPNLYYYAANNPSEAT--IAKRRGYACTISYLTPPAENAGLYKGLQELREMIGSYQTLREGARGIAIVNAICDKARLVNLDKDVD-----LPAGDAAQLSLEERDTVVG------------------------------------------------------------KIYAKLMEIEGLHVIGAPPTAEEAIATLV--SIASIDRPEEGILGLPRILAQSLGRDIDEIYRNRDRGHLADTELLDRINKACQKAVAALVQEQTDAQGRVSRVAKLNFFNMGRQAPWLAVLKEAGYPQVDPDLLKPLFEFLEECLKQITADYELGSLLRALEG---EYILPGPGGDPIRNPNVLPTGRNIHALDPQSIPTAAAIKSAEIVVERLLAREMSSNGGKY-------------------PETISVVLWGTDNIKESLAQVLCLLRPKPDALGRVNK-VELIPLEELGRP--RIDVVVNCSGVFRDLFVNQM---DLIDRAVKLAAAAVE--LNFVRKHALQQAEELGLTLEQAATRVFSYSANINLAVENSSWEDESELREMYLSRKSFAQMRQLFEASLKTVDVTFQNLDSSEISLTDVSHYFDADPTKLVQSLRPDGKAPSAYNAQIRTLSETIRLDARTKLLNPMLKHGYEGVREIAKRLVNTSG-WSATAGAVDNWIYEETNETFIKD................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 1078
5 -10.300PF02463.17; SMC_BACSU/2-1172; RecF/RecN/SMC N terminal domain  ali follow..  10  3...................................KRLDVIGFKSFAERISVD---PNGSGKSNITDAIRWVLGEQSA-GGKMEDIIFAGLPIDFHEVSVTRRVYRSGESEF---INNQPCRLKDIIDLFMDSGL-------GKEAF--SIISQGKVEE-------ILSSKAEDRRSIFEEAKYTRKKKAENKLFETQDNLNRVEDILHE---------------LEGQVEPLKIQASIAKDYLEKK--------KELEHVEIALTAYDIEELHGKWSTLKEKVQMAKEEELAESSAISAKEAKIEDTRDKIQALDESVDELQQVLLVTSEELEKLEGRKEVLKERKKNA------------QNQEQLEEAIVQFQQKETVLKEELSKQEAVFETLQAEVKQLRAQVKEKQQALSLHNENVEEKIEQLKSDYFELLNSQELQLLDDQMSQSAVTLQRLADNNEKHLQERHDISARKAACETEFARIEQEIHSQVGAYRDMQTKYEQKKRQYEKNESA--------------------------LYQAYQYVQQARSKKDMLETMQGDFSGFYQGVKEV---LKAKERLGGIRGAVLELISTEQKYETAIEIALGASAQHVVTDDEQSARKAIQYLKQNSFGRATFLPLSVIRDRVASELVTFDPAYRSVIQNLLGTVLITEDLKGANELAKLLGHRYRIVTL-SLLGRSREEDVTKRLAEMEEKTA---LLEQEVKTLKHSIQDMEKKLADLRETGEGLRLKQQDVKGQLYELQVAEKNINTHLELYDQEKSALSES------DEERKVRKRKLEEELSAVSEKMKQLEEDIDRLTKQKQTQSSTKESLSNELTELKIAAAKKEQACKGEEDNLARLKKELTETELALKEAKEDLSFLTSEMSSSTSGEEKLEEAAKHKLNDKTKTIELIALRRDQRIKLQHG-----------------------LDTYERELKEMKRLYKQKTTLLKDEEVKLGRMEVELDNLLQYLREEYSLSFEGAKEKYQLETDPEEARKRVKLIKLAIEELGTVNLGSIDEFERVNE---------RYKFLSEQKEDLTEAKNTLFQVIEEMDEEMTKRFNDTFVQIRSHFDQVFRSLFGGGRAELRLTDPNDLLHSGVEIIAQPPGKKLQNLNLLSGGERA-ALLFSILKVRPVPFCVLDEVEAALDEANVFRFAQYLKKYSSDTQ.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 1142
6 -10.100PF17072.3; SPIKE_BRV1/1-1583; Torovirinae spike glycoprotein  ali follow..  10  201...........VYQITPYTQYTVTMPSGTSGYCQQTPLYVECGSWTPYRVHAYGCDKQSCNYTISSDWVVAFKSKASAIILRSQLIVALAQKLSRTV-FLKQPYHYLSLVNFSPNYAL----FSPLCKSLRQQSATYSALSYGSPFFVAQYLPDCCLYTLFSILFS-VNNVLQANETFLQLPTTGYLGQTVSQGRMLNLFKDAIVFL-----DFYDTKFYRTNDGPGGDIFAVVVKQVPVIAYSAFRIEQQTGYLAVKCNGVIQATLAPHS-----------------SRVVLLARHMSMWSIAAANSTTIYCPIYTLTSFVRLD-FHTLAQPSGPIQSMPVLSTGAAGVYMHPMLLAQSSVYQPSMFNMGVNKSVTLTTQLQAYAQVYTAWFLSILYTRLPESRRLTLGAQLTPFIQALLSFKQADIDATDVDTVARYNVLILMKYAAVIYNQLPEWSYPLFKGGVGDSMWFRKKFLVTTKIHQTASHFPFIAGYLVACPLSTMVPSILQVYETPQLFVIIVQCVSTTYSWY--PGLRNPHTIYRSYKLGTICVLVPYSSPTDVYSSFGFFFQSALTIPTVQTTDDILPGCVGFVSVFTPCHPSGCPVRNSYDNY---IICPGSSASNYTLRNY-YRTTTPVTNVPIEEVPLQLEIPTVSLTSYELKQSESVLLQDIEGGIVVDHNTGSIWYP-AYDVSFYVSVIIRELPSTLANFTSCLDQTFCTSMDYFEQVFNKSLTSLITAQDLHYVLKLVLPETTLELTEDTRRRRRAVDEDTISLLSESFERFMSPASQAYMANMMWWDEAFDGISLPQRTGSILSSAPSLSSISSWHSYSS--RTPLISNVKTPKTTFNVKLSMPKLPKASTLSTIGSVLSSGLSIASSIFSIIEDRRVIELTQQQIMALEDQITILAGYTTKNFEEIQSSLNTLGQQVQDFSQTSALSLQQLSNGFEQITQQLDKS.......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 1202
7 -9.980PF10266.7; C3Y1H4_BRAFL/22-1097; Hereditary spastic paraplegia protein strumpellin  ali follow..  11  1.....................................................................NAIIAE------RLSEFIPPVFRLDNKR-IITDFSYFRQQDYFDHNIEKR-PDLQDLDEQFRENNIDIL-------------------TRFYLAFESIHKYVTDLNRYLEDLQEGVYIQQTMESVLLNEDGKQLMCE-------------SLFLYGTMLLAVDMKFEGVI-----------------------RERMLVSYHRYSSARAVTD-------SNIDDVCKLLRSTGFNPAPGAKKPANYPESFFKRVPIRPVFISMVIGRLRSDDIYNQHRSTALATQYVILYFAPEILHNQQAKMREIVDKHFPDNWVVSVYMGIIVNLKAAKTALNNTT--EQANVREQAMKYEQCVTKLNPLVKQQLKE--LDSIPKLMNIIRECNVTIHWMLLHTVESGADLNKRCRQLREQVIADSKYNPGILFELLLNLKEMFKQMLQDKQNKWEQFSGTKPLTRNLQAYFNETAKQITSLSYEDSTSAGRKIVQLIQALEEVQEVRQFLADTRKFLHQMIRTINIKEEVLITMSIVGDLSYAWNIIDNYTGHMQQGIKRDPSLVTK--LRAT-FLKLASAMDLPLLRINQANSPDLISVSQYYSGELVTYVRKVL-------QIIPETMFGLLGVIIKMQTSQIKEVPTRLEDKLKEYAQ-LEERAKVAKLTHDISVFTEGILMMKTTLVGIIK-------VDPKQLLEDGIRKELVKRVAYALHQG-LIFNPKSKVSELIPRLNGMGAVMDGFRRSFE--IQDYVSISGLKIWQEEVSRIINYNVEQ............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 756
8 -9.950PF11725.6; Q887C9_PSESM/17-1794; Pathogenicity factor  ali follow..  934.QDLKARITALEAKLGPQGATLVKELETLRDELENH--SYTALMSIG---KAKNLKQQDGILNQHGELAKPSVRMQFGKKLADLGTKLNFKSSGHDLVKELQDALTQVAPSAENP-------TKKLLGTLKHQGLKLIPLGQRRDASEDHGL---SKARL--VTLKSLGALLDQVEQLPPQSDIEPLQKKLATLRDVTYGENPVKVVTD--------------MGFTDNKALESGYESVKTFLKSFKKAVSVNMRAATGSKDQAELAGKFKSMLKQLEHGDDEVGLQRSYGVNLTTPFII---------LADKATGLWPTAGATGNRNYILNAERCEGGVTLYLISEGAGNVSGGFGANPARSVDVGNNRTLTPNFRLGVDVTATVAASQRAGVVFNVPDEDIDAFVDDLFEGQLNPLQVLKKAVDHESYEARRFNFDLTAGGTADIRAGINLTEDRDPNADPNSDSFSAVVRGGFAANITVNLMTYTDYSLTQKNDKTELKEGGKNRPRFLNNVTAGGQLRAQIGGSHTAPTGTPASAPGPTPASQTAANNLGGALNFSVENRTVKRIKFVAKPGEAFLDNTTKAKLAELADPLNA-----RYTGKKPDEVIQAQLDGLEELFADIPPPKDNDKQYKALRDLKRAAVEHRASANKHSVMDNARF-LSGLSSESILTKIMSSVRDASAPG-------NATRVAEFM-RQDP-KLRAMLKEMEG-------------SIGTLARVRLEPKDSLVDKIDEGSLNGT----------MTQSDLSSMLEDRNEMRIKRLVVFHTATQAENFTSPTPLVSYNSGANVSVTKTLGRINFVYGADQ--DKPIGYTFDGELSRPSASLKE................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 1765
9 -9.360PF00946.17; Q6YIR9_FDLV8/10-1113; Mononegavirales RNA dependent RNA polymerase  ali follow..  301LSELDQLLKEDTILSTGEVKDFIELISEIINMGSVSEISVTAADKVRDHMCKPKVLDYETLQKGHAVFCSMIINGFRERHGGSWPPCFLPDYASSELKAVMANHAAIPYELSVNNWESKFDKFEEVNLDE-----DLTIFMKDKASPIRAEWDTVYPQENRRLVDVFLE----------MEFNPQDIIDYVVSDQDFNISY----SLKEKEIKQAGRLFAKMTYKMRAAQVLAEVAHGVGKYFQ-----------ENGMVKDEHELLKSLTTL---------------SLAGVPRSRPGEDPSATEESKFVKIAQKGKEILRNNQTRRSTQESRDQDGLANEKHETVASFITTDLQKFCLNWRYESVIL----------------FAQRLDEIYGLPGFFEWLHKRLEKSVLYVADPNCPPDFRTKMSLEDTPD-YSQKMWTIISISMIHLAAVQTGVRVSAVIQGDNQSIAVTTRVPVRMNYNQKKTECYKSTIRYFETLRKVMGG--------------NLKLNETIISN---------FFIYSKR--------------------------------IYFDGSILPQGLKTISRCVFWSETLVDETRAACS----NISTSLAKAVENGISPLLCYLLNAWKTLINPTITKDLYGPILSSQDWMIIAV---IVPSQLGG---------------FNYMSLSRLFVRNIGDPLVAALADVKRYIEGDSTELDWASDPYSANPHSQSVTTVIKHVTARSVLSKSP----------NPMLEGLFHENTDEEDHDLARFLIREIILPRVANVILDQSGARSAIAGLLDTTKTLIKNTANKGGLSNRTVSKLLYHDYQQFIVFNK................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................. 1102
10 -9.350PF15962.3; A9MQT6_SALAR/12-1138; Domain of unknown function (DUF4765 topsan)  ali follow..  12  159.......LLDLFLKHILYDDKVDHEVTNLYSNVIYKEIDSTAMAHASLCFSQAAVSDKHELFNIDSKSTEQVIFAGEEI--NIKNIAVTGLLLSSRLTIADGYGRKNDNSENKNNFSSDKEPLRALPEDHPAPNMEPHPL----GKMIDGIVEHSSFAAGISLFETLKKIGDEQ-----LMNDYKRGYHELLVFSQTGQWTHG----RRLTAEYMFNGLIIHLNEIEILINDGGK------SFEHFVREHIEHQYKIYELIARDMLVHPIYIRSRIFATRRIASALANESHYTKVLNQKFPEISSSNFDTFYGKEAIFTALK-------IVNYYREEKGMPTFNSKKRVQLVIRHLSRNGGDKILLSPDGIKYNFSIMRNIIYWCAKPVNDKKI------NALSRKIVVNNEFSRHIKSLFPRG-----NGFLELLMKAAIDTQLNWAEK--------YYKAVTHVKDHIQDCDVLGLMN-------KMLRDTVVGLIHEISDIAQSSWLTAEDQHEK---QVQALEAFKSKVSSMDG-GQAFVY---------FDKVIQEGLWGLIELSFDIDDTVHHRTVSS-------------------------------------LSPASRAGLHFLGTIWIVMSFVPGFNALAGTSSILNRAIVEKSTDVCGYIQDVIRIGMEAAPVAEAKFTERLRFVIERGVIRSPIQKGSNYKVIESIENID-FIYQKRNNKILELNPEGNDGLYRAT-----------FNKETHGYYKQSGEGFYRKQKSF-LSTEAPNTIKYGERLSKEPGSETYQGTFSDTGKNVGMTFYRTSDG................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 927
11 -9.260PF11894.6; C5DMA7_LACTC/4-1647; Nuclear pore complex scaffold, nucleoporins 186/192/205  ali follow..  10  573....LSSLYTLIGCVAHDLNELSSLFTDILFEFVKVDTPLVGLKVLSNLVPYDELERSKFWFNLDSWIFKGFRLTISDDSY---ESILTHFQDITGFLQLLNSLLKVRTKSTNGYLEFGLLQFPKLGHGYRKLGIWVFHGILAQSNKLPNPAERAIHKPILEILSSALSSFDYS-NYLFEENVFKNLLQNASF------GVEKMGSITEEDCQSLALPCLA--------LSTINQVLTIQETYVEELCPIVKKSASKNYFIPKDFGLHGLRSFYDAISFDLPLIVGIGLYVGHTNYKIASNSLDI-----DKISTEMKGRDSQAIVKDKLLSVFDSVDESARISITNYESFSIKMRILDFISKNLSYTDKQPT----AHFLLGLQIGNTISLGPDLSTFVTSGCSVLTSIIYLLQS---SLMVLSSEEIEFLPAKLASSSMEILLKLCKNSATSKIVLRHMSESDF-AGDSLGFIKQTSTGAFLSFLSALQYLSLDI-KSRIKSRIDLLISNYLQPPRLFSFLDALNFDARKVLSGINFNLPSLQKVTPCTELIYSLIRLRTQFLGKHLPLNFHEETITNKETLDRISGAEAATIEKHLTDYMSFEQFKSLQLSLLLVQVVVLPQVSISDFILRLFEAIVPKINDYVELDLYDLYQKDQKLNNDGRLIALFLACINGIRSPLSTLAL---RSDFYILANRFL---SIMKEVNTAKQVLKTLKLTSE---RLVEVVCNDAISGEGSSRITGILF--LDSLVQIAGLNKVNFVLESLVKSMLLLISHSIKTTDDLLSSGLEGITLDNLLYELTA-FKSTIHFLIRIAESRSGA------QALVENEIFRVIES............................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................ 1516
12 -9.030PF00747.15; DNBI_EBVB9/5-1087; ssDNA binding protein  ali follow..  104LEALCGETREVYDAYSALPRESSKPGDFFPEGLDPSVAITEAFK--KQEVAVGQSASVRVPLYDKEVFPEGVPQLRQFYNSDLSRCM--EALYTGLAQALRVRRVGKLVELLEKQSLQDQAKVAKVAPLKEFPASTI-----SHPDSGALMIVDSAACELAVSYAPAMLEASHETPASLNYDSWEARVAALHRYNASLAPHVSTQIFATNSVLYVSGVSKSTGQGKESLFNSFYMTHGLGTLQE---GTWDPCRRPCFSGWGGPDVTGTNGPGNYAVEHLVYAASFSPNLLARYAYYLQFCQGQKSSLTPVPETGSYVAGAAASPMAVCLNTLFFRLRD-PVMSTQRRDPYVIETDFLGNFLNFIDKEDDGQRPDDEPRYTYWQLNQNLLERLSRLGIDAEGKLEKEPHGPRDFVKMFKDVDAAVDAEVVQFMNSMAKNNI----TYKDLVKSCYHVMQYSC-----NPFAQPACPIFTQLFYRSLLTILQDISLPICMCYENDNPGLGQSPPEWLKGHYQTL------CTNFRSLAIDKGVLTAK---------EAKVVHGEPTCDLPDLDAALQGRVYGR---RLPVRMSKVLMLCPRNIKIKNRVVFTGENAALQNSFIKSTTRRENYIIN----YMKFLNTYH-----KTLFPDTKLSSLYLWHNFSRRRSVPVPSGASAEEYSDLALFVDGGSRAHEESNVIDVVPGNLVTYA---------KQRLNNAILK---------GQTQFYISLIQGLVPRTQSVPARDYPHVLGTRAVESAAAYAEA------SSLTATTVVCAATDCLSQVCKARPVVINKYTGVNGNNQIFQAGNL....................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 931

FFAS is supported by the NIH grant R01-GM087218-01
1 1 1 6 2 2   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Alexey M. Eroshkin, Andrew LeBlanc, Dana Weekes, Kai Post, Zhanwen Li, Akhil Rajput, Sal T. Butera, Dennis R. Burton, Adam Godzik. bNAber: database of broadly neutralizing HIV antibodies. Nucl. Acids Res. 2013; published on November 7, 2013.

Damiano JS, Stehlik C, Pio F, Godzik A., Reed JC. CLAN, a novel human CED-4-like gene. Genomics. 2001 Jul;75(1-3):77-83.